ClinicalTrials.gov
ClinicalTrials.gov Menu

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02128230
Recruitment Status : Recruiting
First Posted : May 1, 2014
Last Update Posted : October 16, 2018
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
University of Arkansas

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2025
  Estimated Study Completion Date : May 2025